In vitro activity of colistin plus sulbactam against extensive-drug-resistant acinetobacter baumannii by checkerboard method

Journal of the Medical Association of Thailand

Volumn 97, Issue 3 SUPPL. 3, 2014, Pages

  Thamlikitkul, Visanu ^a   Tiengrim, Surapee ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

A. baumannii; Colistin; Sulbactam; Synergy

Indexed keywords

COLISTIN; SULBACTAM; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CHECKERBOARD METHOD; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENTIATION; DRUG SENSITIVITY; FRACTIONAL INHIBITORY CONCENTRATION INDEX; IN VITRO STUDY; INOCULATION; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROCEDURES; DRUG COMBINATION; DRUG EFFECT; HUMAN; METHODOLOGY; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; COLISTIN; DRUG COMBINATIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; HUMANS; MICROBIAL SENSITIVITY TESTS; SULBACTAM;

EID: 84899999628     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Falagas ME, Karageorgopoulos DE. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis 2008; 46: 1121-2.
2. Chung DR, Song JH, Kim SH, Thamlikitkul V, Huang SG, Wang H, et al. High prevalence of multidrug-resistant nonfermenters in hospitalacquired pneumonia in Asia. Am J Respir Crit Care Med 2011; 184: 1409-17.
3. Koomanachai P, Tiengrim S, Kiratisin P, Thamlikitkul V. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand. Int J Infect Dis 2007; 11: 402-6.
4. Petrosillo N, Ioannidou E, Falagas ME. Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies. Clin Microbiol Infect 2008; 14: 816-27.
5. Michalopoulos A, Falagas ME. Treatment of Acinetobacter infections. Expert Opin Pharmacother 2010; 11: 779-88.
6. Lorain V. Antibiotics in laboratory medicine. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.
7. Santimaleeworagun W, Wongpoowarak P, Chayakul P, Pattharachayakul S, Tansakul P, Garey KW. In vitro activity of colistin or sulbactam in combination with fosfomycin or imipenem against clinical isolates of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemases. Southeast Asian J Trop Med Public Health 2011; 42: 890-900.
8. Deveci A, Coban AY, Acicbe O, Tanyel E, Yaman G, Durupinar B. In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates. J Chemother 2012; 24: 247-52.